N-Methylazetidine-3-carboxamide hydrochloride, 98%, 100mg

2,7-Dibromo-2',3',5',6'-tetrahydrospiro[fluorene-9,4'-pyran], 95.0%, 5g

3-Iodobiphenyl>98.0%(GC)5g

5-(4-Ethoxybenzoyl)-2-methylpyridine, 97.0%, 1g

trans-4-Methoxyphenyl 4-pentylcyclohexanecarboxylate, 95%, 25g

2-Chloro-n-(pyrimidin-2-yl)propanamide, 95%, 5g

1-(4-Iodophenyl)prop-2-en-1-amine, 250mg

1,4-DI(PYRIDIN-4-YL)BENZENE, 97.0%, 1g

ROTI®Pol Hot-TaqS, 200 µl, 5 x 40 µl

2-Fluoro-6-methylbenzylamine, 98.0%, 250mg

Tesevatinib, 99.21%, 5mg

Ethyl 1-methyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxylate, 95.0%, 100g

(4,5-Dimethoxy-2-nitro-phenyl)-acetic acid, 98%, 1g